Indiana University Melvin and Bren Simon Comprehensive Cancer — Indianapolis, Indiana

Indiana University Melvin and Bren Simon Comprehensive Cancer is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Indiana University Melvin and Bren Simon Comprehensive Cancer has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Colorectal Cancer Stage II, Colorectal Cancer Stage III.

Sponsors: BioNTech SE.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University Melvin and Bren Simon Comprehensive Cancer?

Indiana University Melvin and Bren Simon Comprehensive Cancer has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University Melvin and Bren Simon Comprehensive Cancer conducted?

Indiana University Melvin and Bren Simon Comprehensive Cancer has 1 clinical trials on record, with 1 currently active. Their work covers Colorectal Cancer Stage II, Colorectal Cancer Stage III.

Is Indiana University Melvin and Bren Simon Comprehensive Cancer accredited by Crixeo Health?

Indiana University Melvin and Bren Simon Comprehensive Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana University Melvin and Bren Simon Comprehensive Cancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.